Meeting
2014 ASCO Annual Meeting
Patient-reported endocrine symptoms, sexual functioning, and quality of life (QoL) in the IBCSG TEXT and SOFT trials: Adjuvant treatment with exemestane (E) plus ovarian function suppression (OFS) versus tamoxifen (T) plus OFS in premenopausal women with hormone receptor-positive (HR+) early breast cancer (BC).
Authors
Juerg Bernhard
International Breast Cancer Study Group, Bern, Switzerland
Juerg Bernhard , Weixiu Luo , Karin Ribi , Marco Colleoni , Harold J. Burstein , Carlo Tondini , Graziella Pinotti , Simon Spazzapan , Thomas Ruhstaller , Fabio Puglisi , Lorenzo Pavesi , Vani Parmar , Meredith M. Regan , Olivia Pagani , Gini F. Fleming , Prudence A. Francis , Alan S. Coates , Richard D. Gelber , Aron Goldhirsch , Barbara Walley
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
ER+
Clinical Trial Registration Number
NCT00066783/NCT00066690
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 557)
DOI
10.1200/jco.2014.32.15_suppl.557
Abstract #
557
Poster Bd #
21
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Optima: Optimal personalised treatment of early breast cancer using multi-parameter analysis, an international randomized trial of tumor gene expression test-directed chemotherapy treatment in a largely node-positive population.
First Author: Rob C. Stein
Poster
2014 ASCO Annual Meeting
Estrogen levels in premenopausal (prem) patients (pts) with hormone-receptor positive (HR+) early breast cancer (BC) receiving adjuvant triptorelin (Trip) plus exemestane (E) or tamoxifen (T) in the SOFT trial: SOFT-EST substudy.
First Author: Meritxell Bellet
Poster
2023 ASCO Annual Meeting
Influence of ovarian function supression on quality of life in breast cancer survivors during adjuvant endocrine therapy.
First Author: Natalija Dedic Plavetic
Poster
2024 ASCO Breakthrough
Exploring depression risk among breast cancer survivors: A nationwide cohort study in South Korea.
First Author: Hea Lim Choi